1. A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands. Issue 30 (9th July 2019) Authors: Gessner, Bradford D.; Jiang, Qin; Van Werkhoven, Cornelis H.; Sings, Heather L.; Webber, Chris; Scott, Daniel; Gruber, William C.; Grobbee, Diederick E.; Bonten, Marc J.M.; Jodar, Luis Journal: Vaccine Issue: Volume 37:Issue 30(2019) Page Start: 4147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands. Issue 38 (10th September 2019) Authors: Gessner, Bradford D.; Jiang, Qin; Van Werkhoven, Cornelis H.; Sings, Heather L.; Webber, Chris; Scott, Daniel; Neuzil, Kathleen M.; O'Brien, Katherine L.; Wunderink, Richard G.; Grobbee, Diederick E.; Bonten, Marc J.M.; Jodar, Luis Journal: Vaccine Issue: Volume 37:Issue 38(2019) Page Start: 5777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection. Issue 41 (24th September 2019) Authors: Patel, Nita; Massare, Mike J.; Tian, Jing-Hui; Guebre-Xabier, Mimi; Lu, Hanxin; Zhou, Haixia; Maynard, Ernest; Scott, Daniel; Ellingsworth, Larry; Glenn, Gregory; Smith, Gale Journal: Vaccine Issue: Volume 37:Issue 41(2019) Page Start: 6112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗